胰腺细胞由于过度活跃的ERK/MAPK信号和诱导亡,对KRASQ61L表达具有抗性
Rachel A Burge1, Lucas Bialousow1, Thomas McFall2
1Department of Biochemistry & Molecular Biology, Medical University of South Carolina, Charleston, South Carolina.
Cancer research communications
|September 15, 2025
概括
在癌症中常见的KRASQ61L突变,通过过度激活ERK/MAPK通路,令人惊地限制了胰腺瘤的生长,导致细胞死亡,并支持瘤信号的"金发子"模型.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症遗传学 癌症遗传学
背景情况:
- 人类癌症中RAS GTPases经常发生突变,特别是胰腺管道腺癌 (PDAC) 中的KRAS.
- 虽然在PDAC中12和13编码子的KRAS突变很常见,但KRASQ61L特别罕见,这表明基因特异性机制限制了其致癌潜力.
- 了解这些机制对于识别KRAS因子和驱动瘤发生的途径至关重要.
研究的目的:
- 调查KRASQ61L在PDAC中流行率较低的机制基础.
- 为了比较KRASQ61L的信号传递和细胞后果与常见的PDAC突变KRASG12D.
- 阐明ERK/MAPK通路过激活在KRAS驱动的胰腺癌中的作用.
主要方法:
- 在同位素胰腺细胞系中利用了可诱导多西环素的KRAS表达系统.
- 采用TurboID近距离标记和RNA测序来绘制早期效应器相互作用和转录反应的地图.
- 对比了KRASQ61L和KRASG12D过度表达对细胞增殖和细胞亡的影响.
主要成果:
- 与KRASG12D相比,KRASQ61L诱导了ERK/MAPK通路的更大过激活,导致ERK1/2.2.的核转移增加.
- 胰腺细胞表现出对KRASG12D过度表达的耐受性,但在KRASQ61L过度表达时,增殖受损和亡增加.
- 这些发现支持"金髮女孩"模型,其中过度的ERK/MAPK激活对瘤发生有害.
结论:
- 由于KRASQ61L对ERK/MAPK信号的强烈过度激活,导致了亡,限制了其驱动胰腺瘤发生的能力.
- 这为PDAC中选择性缺失KRASQ61L的机制性解释提供了解释.
- 该研究强调了KRAS等位基特异性的脆弱性,并为KRAS驱动的胰腺癌提供了潜在的治疗策略.
相关概念视频
01:19Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
01:07MAPK Signaling Cascades
7.9K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.9K
01:22PI3K/mTOR/AKT Signaling Pathway
5.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.4K